Interface Clinical Services Ltd

Active06076464 Private limited company
Incorporated
31 January 2007 (19 years)
Industry
Other human health activities (86900)
Owned by
Accounts type
Medium
Region
South East
Address
3 Forbury Place
23 Forbury Road
Reading
RG1 3JH

Filing status

Accounts due
31 December 2026
Last accounts
31 December 2024
Conf. stmt due
14 February 2027
Last conf. stmt
31 January 2026

Charges

Total
1
Outstanding
0
Part satisfied
0
Satisfied
1

Officers 4 active

Officer details are public data from the Companies House register.

Director · Appointed 9 August 2023
British
Born November 1962
Corporate Secretary · Appointed 21 July 2023
Director · Appointed 9 July 2020
British
Born January 1971 (55)
Director · Appointed 9 July 2020
British
Born April 1977 (49)
Officer history (10 former)
9 August 2023
Appointed Simpson, Paul David as Director
9 August 2023
Resigned Fox, Lee Robert as Director
21 July 2023
Resigned Halco Secretaries Limited as Corporate Secretary
21 July 2023
Appointed Jtc (UK) Limited as Corporate Secretary
9 July 2020
Appointed Halco Secretaries Limited as Corporate Secretary
9 July 2020
Resigned Mcardle, James as Director
9 July 2020
Appointed Fox, Lee Robert as Director
9 July 2020
Appointed Mecci, Imran as Director
9 July 2020
Resigned Davis, Steven as Director
9 July 2020
Resigned Tate, Mark as Director
9 July 2020
Appointed Sheppard, Timothy Peter as Director
9 July 2020
Resigned Fort, Michael John as Director
9 July 2020
Resigned Patel, Omar as Director
9 July 2020
Resigned Drakard, Sue as Secretary
9 July 2020
Resigned Drakard, Michael as Director
16 October 2014
Appointed Davis, Steven as Director
16 October 2014
Appointed Tate, Mark as Director
16 August 2012
Appointed Fort, Michael John as Director
29 November 2011
Resigned Drakard, Michael as Secretary
29 November 2011
Appointed Drakard, Sue as Secretary
19 December 2008
Appointed Mcardle, James as Director
31 January 2007
Appointed Drakard, Michael as Secretary
31 January 2007
Appointed Drakard, Michael as Director
31 January 2007
Appointed Patel, Omar as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 9 July 2020
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Company Limited By Shares
Reg. no. 03022416
Former controllers (1)
9 July 2020
Ceased Michael Drakard — Owns 50–75% of shares

Group structure 19 shown

Ownership group derived from the Companies House PSC register

Iqvia RDS Holdings Owns 75–100% of shares
Iqvia Finance Ltd. Owns 75–100% of shares
Iqvia Ltd. Owns 75–100% of shares
Apira Limited Owns 75–100% of shares
Arc Bio Communications Limited Owns 75–100% of shares
Clintec International Ltd. Owns 75–100% of shares
Cro Solutions Limited Owns 75–100% of shares
Drugdev Limited Owns 75–100% of shares
Epg Communication Holdings Limited Owns 75–100% of shares
Gce Clin Solutions Limited Owns 75–100% of shares
Interface Clinical Services Ltd This company Owns 75–100% of shares
Iqvia Biotech Ltd. Owns 75–100% of shares
Iqvia Investment Holdings Limited Owns 75–100% of shares
Iqvia Solutions Finance UK V Ltd. Owns 75–100% of shares
Iqvia Solutions UK Limited Owns 75–100% of shares
Iqvia Technology Services Ltd. Owns 75–100% of shares

Financials

Balance sheet as at 31 December 2024 · medium accounts

Net Assets
£15,364,800
Cash
£3,122,967
Turnover
£26,342,263
Profit Before Tax
£7,856,710
Employees
253
Debt Ratio
36%
Current Ratio
2.7x
Profit Margin
30%
Return on Equity
38%

Trend

Turnover
£0 £20.0M £40.0M 2022 2023 2024 £16,021,182 £21,371,335 £26,342,263
Balance sheet detail
20242023202220212020
Fixed Assets£138,608£107,874£122,838£101,620£121,107
Current Assets£24,057,592£14,982,502£10,674,841£12,068,910£4,298,436
Debtors£20,934,625£8,035,705£5,302,612£3,822,155£2,105,047
Cash£3,122,967£6,946,797£5,372,229£8,246,755£2,193,389
Creditors (< 1 year)£8,803,431£5,599,290£4,264,935£7,587,562£1,701,062
Net Current Assets£15,254,161£9,383,212£6,409,906£4,481,348£2,597,374
Net Assets£15,364,800£9,472,451£6,512,219£4,570,567£2,708,752
Shareholder Funds£15,364,800£9,472,451£6,512,219£4,570,567£2,708,752

Turnover£26,342,263£21,371,335£16,021,182
Cost of Sales£13,644,276£12,528,294£8,767,678
Gross Profit£12,697,987£8,843,041£7,253,504
Admin Expenses£5,641,298£5,085,231£4,902,868
Staff Costs£17,236,014£15,847,434£12,073,468
Operating Profit£7,056,689£3,757,810£2,350,636
Profit Before Tax£7,856,710£3,870,554£2,396,056
Tax£1,964,361£910,322£454,404
Profit for Period£5,892,349£2,960,232£1,941,652

Filings 100

DateDescriptionMade Up ToPagesPDF
27 October 2026Director's details changed
13 February 2026Confirmation statement with no updates31 January 2026
23 September 2025Accounts for a medium company31 December 2024
17 June 2025Full accounts31 December 2023
6 February 2025Confirmation statement with no updates31 January 2025
Show all 100 filings

Some other companies at this address

Other companies in this industry

By trade and location

New Medical & Health Practices →New companies in Reading →New Medical & Health Practices in Reading →

Explore the largest companies

Largest healthcare companies in the UK →Largest companies in Reading, UK →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?